Knowable Magazine reports on breakthroughs in HIV treatment; engineered antibodies show promise for long-term control, ...
Investigational Treatment Regimen Could Expand Options for Virologically Suppressed Adults –– Positive Phase 3 Results from ...
Today, we confront emerging threats from a range of respiratory viruses, insect-transmitted viruses, and viruses we have not ...
The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that ...
The revolution of artificial intelligence has yet to find its way into clinical practice in oncology. We highlight eight specific challenges, focused on diagnostics, that will enable this translation ...
Two early trials found that engineered antibodies can lead to long-term HIV remission without ongoing treatment — not a full ...
The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in ...
The HIV Stigma Index 2.0, to be released on Tuesday, examines the lived realities of more than 5 000 participants across all ...
With routine check-ups, healthy habits, and community support, people living with HIV can protect their heart, manage weight, ...
Malawi on Thursday, December 4, authorised the use of the injectable HIV prevention drug lenacapavir, becoming the fourth ...
Malawi yesterday launched Lenacapavir, a twice-yearly injectable HIV prevention medicine amid reflections on whether the ...
The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback